Lee Brown with Third Bridge argues that demanding expectations are built into Eli Lilly's (LLY) stock following a "monstrous" 2Q earnings report. Mounjaro and Zepbound no longer on short supply helps the outlook, but Lee looks into other headwinds facing the pharmaceutical company, including the ILA Union's port worker strike.
Market On Close
03 Oct 2024
SHARE